ResultsIQ › Latest results › Bhagiradha Chemicals & Industries Limited

Bhagiradha Chemicals & Industries Limited Q1 FY27 results deck summary

NSE: BHAGCHEM · BSE: 531719

Results deck of 6 Aug 2026, summarised by AI from the filing.

Q1 FY27 revenue ₹195.0 cr, up 58% YoY, with EBITDA ₹30.5 cr and PAT ₹13.3 cr; management expects healthy growth in FY27.

Key takeaways

Revenue Q1 FY27 revenue ₹195.0 cr, up 58% YoY from ₹123.8 cr
Guidance Management expects healthy growth in revenue and profitability during FY27
Change Bheema Fine Chemicals capacity utilisation nearly doubled vs Q4 FY26
Driver Higher volumes, improved realisations, new molecules and Bheema ramp-up drove growth
Risk Select crude-linked inputs saw price increase due to geopolitical developments in West Asia

Original filing on BSE

Bhagiradha Chemicals & Industries Limited Q1 FY27 results

As filed: Revenue ₹195 cr (+57% year on year), EBITDA ₹30.5 cr (+239% year on year), PAT ₹13.3 cr (+233% year on year), EBITDA margin 15.7% (+840 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

Q4 FY26: Revenue ₹158 cr (+29% year on year), EBITDA ₹19.4 cr (+178% year on year), PAT ₹4.1 cr, EBITDA margin 12.3% (+660 bps). Score 85 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 660 bps year on year. Profit fell 12% from last quarter. Revenue rose ₹35.1 cr on a year ago, more than the ₹12.0 cr it added the year before. Share price after the results: +3.9% in 30 days (Nifty 500: +3.0%).
Q3 FY26: Revenue ₹114 cr (+11% year on year), EBITDA ₹13.7 cr (+37% year on year), PAT ₹4.6 cr (+16% year on year), EBITDA margin 12.0% (+229 bps). Score 62 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was above it. EBITDA margin rose 229 bps year on year. Consolidated profit +16% but standalone -31%. Revenue fell 19% from last quarter. Share price after the results: −11.3% in 30 days (Nifty 500: −7.8%).
Q2 FY26: Revenue ₹140 cr (+35% year on year), EBITDA ₹16.0 cr (+60% year on year), PAT ₹6.0 cr (+20% year on year), EBITDA margin 11.4% (+181 bps). Score 69 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was in line with it. EBITDA margin rose 181 bps year on year. Consolidated profit +20% but standalone -25%. Share price after the results: −6.9% in 30 days (Nifty 500: −0.8%).
Q1 FY26: Revenue ₹124 cr (+12% year on year), EBITDA ₹9.0 cr (−25% year on year), PAT ₹4.0 cr (−33% year on year), EBITDA margin 7.3% (−355 bps). Score 35 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 355 bps year on year. Other income 33% of PBT. Tax rate -33%. Consolidated profit -33% but standalone +14%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −6.9% in 30 days (Nifty 500: +2.4%).
Q4 FY25: Revenue ₹123 cr (+11% year on year), EBITDA ₹7.0 cr (−53% year on year), PAT −₹1.0 cr (−114% year on year), EBITDA margin 5.7% (−782 bps). Score 20 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 782 bps year on year. Other income 50% of PBT. Tax rate 150%. Profit fell 125% from last quarter. Share price after the results: −8.9% in 30 days (Nifty 500: +3.7%).
Q3 FY25: Revenue ₹103 cr (+39% year on year), EBITDA ₹10.0 cr (+11% year on year), PAT ₹4.0 cr (+33% year on year), EBITDA margin 9.7% (−245 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 245 bps year on year. Other income 33% of PBT. Profit fell 20% from last quarter.
Q2 FY25: Revenue ₹104 cr (−15% year on year), EBITDA ₹10.0 cr (−29% year on year), PAT ₹5.0 cr (−17% year on year), EBITDA margin 9.6% (−186 bps). Score 0 of 100, Below trend. EBITDA margin fell 186 bps year on year. Other income 38% of PBT. Tax rate 38%. Consolidated profit -17% but standalone +33%. Not enough history for a trend yet: scored on growth alone. Revenue fell 6% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Bhagiradha Chemicals & Industries Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.